Invesaro

Stocks RNG Financial statements

Financial statements

RingCentral, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data RingCentral, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3805046749031,1841,5951,9882,2022,4002,515
Cost of revenue92.2121157231324448642664706723
Gross profit2883825166728601,1461,3471,5381,6951,792
Research and development65.575.1101136189310362336329317
Selling and marketing1802403294395848541,0571,0681,0961,096
General and administrative55.572.3103142200284293333266258
Operating expenses3013885337179731,4481,9961,7371,6921,671
Operating income-12.9-5.34-16.4-45.7-113-302-649-1992.67121
Interest expense0.750.116.120.549.364.44.81366560.3
Other non-operating income-3.121.39-9.63-11.331.2-71.9-22542-49.9-64.3
Pre-tax income-16-3.95-26.1-56.9-82.1-374-874-157-47.256.2
Income tax0.240.260.14-3.330.932.535.118.411.112.8
Net income-16.2-4.2-26.2-53.6-83-376-879-165-58.343.4
EBITDA1.810.96.84-7.81-37.6-176-40335.1225343
EPS, basic-0.22-0.06-0.33-0.64-0.94-4.10-9.23-1.74-0.630.48
EPS, diluted-0.22-0.06-0.33-0.64-0.94-4.10-9.23-1.74-0.630.48
Shares, basic (weighted)7376.379.583.188.791.795.294.992.189.5
Shares, diluted (weighted)7376.379.583.188.791.795.294.992.191.2

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents160181566344640267270222243133
Receivables30.246.794.4130176233311364386384
Inventory0.060.20.20.40.555.661.211.491.240.93
Other current assets5.477.628.778.727.516.331.343.518.337.1
Total current assets206265708536926651796849871765
Property, plant and equipment3243.370.289.2142167185184181187
Lease right-of-use assets039.351.147.335.44346.530.9
Goodwill9.399.3931.255.357.355.554.367.48397.8
Intangible assets2.241.4619.5127118717528394259135
Long-term investments01322132104.56
Other non-current assets3.092.9710.29.568.568.1135.81214.913.2
Total assets2533608941,4512,1852,5792,0741,9451,7801,481
Accounts payable7.817.3210.134.6547062.753.321.927.7
Accrued liabilities48.355101139211280380326284298
Deferred revenue45.262.988.5107142176210234262269
Short-term debt14.5020181624
Total current liabilities1161251992814385266536337491,219
Long-term debt0.311,6381,5251,348630
Lease liabilities028.538.731.820.228.229.714.4
Other non-current liabilities6.286.2510.88.9320.284.145.861.84.937.53
Total liabilities1231315777051,8722,0412,3572,2482,1311,870
Total debt14.81,6381,5601,5291,254
Paid-in capital3674355511,0336741,0871,0601,2051,2151,123
Retained earnings-240-210-236-289-372-749-1,534-1,699-1,757-1,714
Other comprehensive income2.7432.231.956.810.64-8.78-8.22-8.882.46
Shareholders' equity164228318746308339-483-503-551-588
Total equity164228318746308339-483-503-551-588
Total liabilities and equity2533608941,4512,1852,5792,0741,9451,7801,481

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-16.2-4.2-26.2-53.6-83-376-879-165-58.343.4
Depreciation and amortization14.716.223.337.975.6125247234223223
Stock-based compensation30.842.168.1101190358386427339270
Deferred income tax-0.04-0.05-0.3-3.95-0.66-1.8-0.70.63-3.642.17
Change in receivables-11.9-17.9-47.9-37.2-52-64.9-87.8-57.8-30.5-13.8
Change in inventory2.25
Change in payables1.520.182.7821.821.917.9-6.17-21.2-29.84.1
Cash from operations29.741.272.164.8-35.2152191400483617
Capital expenditures-14.2-19.5-27.1-27.8-43.6-29-32.7-23.5-25-30.1
Acquisitions0-26.4-27.9000-14.7-26.3-20.8
Purchases of investments00-1360-11.9
Cash from investing-16.4-26.4-83.4-297-108-397-87.2-90.4-109-108
Debt repaid-3.75-14.80000-10-20-0.63
Share buybacks0-15000-99.8-311-322-334
Cash from financing9.336.783979.04438-127-98.2-358-351-623
Exchange rate effect-0.72-0.80.171.53-0.96-3.061.02-2.223.71
Net change in cash22.820.8385-223296-3732.82-47.820.6-110
Free cash flow15.521.74537.1-78.8123159376458587
Interest paid0.710.120.040.190.220.310.3516.65954
Income taxes paid0.230.220.4310.871.393.7310.917.812.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $76.16 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin71.8%Gross profit / revenue.
Operating margin6.7%Operating income / revenue.
EBITDA margin12.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin4.7%Pre-tax income / revenue.
Net margin4.3%Net income / revenue.
FCF margin24.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin26.0%Cash from operations / revenue.
Effective tax rate9.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)8.0%Net income / average total assets.
Return on invested capital (ROIC)39.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue12.5%Research and development expense / revenue.
Stock-based pay / revenue9.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.3%Capital expenditures / revenue.
D&A / revenue6.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y4.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.1%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y16.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y5.7%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y10.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y15.8%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y4,415.0%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y52.3%EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y27.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y47.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y28.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y54.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y-16.8%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-10.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-7.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.11xCurrent assets / current liabilities.
Quick ratio0.76x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.17x(Cash + short-term investments) / current liabilities.
Debt / assets81.1%Total debt / total assets.
Liabilities / assets129.7%Total liabilities / total assets.
Net debt$1.01BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.04xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.84xOperating income / interest expense.
Working capital$70.6MCurrent assets - current liabilities.
Goodwill and intangibles / assets13.0%(Goodwill + intangible assets) / total assets.
Tangible book value-$790.5MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.87xRevenue / average total assets.
Fixed asset turnover13.6xRevenue / average property, plant and equipment.
Inventory turnover735xCost of revenue / average inventory.
Days inventory0 days365 x average inventory / cost of revenue.
Receivables turnover6.64xRevenue / average receivables.
Days sales outstanding55 days365 x average receivables / revenue.
Days payables11 days365 x average accounts payable / cost of revenue.
Cash conversion cycle45 daysDays inventory + days sales outstanding - days payables.
FCF conversion578.8%Free cash flow / net income, when net income is positive.
Capex / operating cash flow4.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$1.27Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$29.83Revenue / diluted weighted shares.
FCF per share$7.37Free cash flow / diluted weighted shares.
Operating cash flow per share$7.74Cash from operations / diluted weighted shares.
Book value per share-$7.05Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$9.13Tangible book value / shares outstanding.
Cash per share$1.29(Cash + short-term investments) / shares outstanding.
Buybacks / FCF67.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$6.36BShare price x shares outstanding.
Enterprise value$7.37BMarket cap + total debt - cash - short-term investments.
P/E57.7xMarket cap / net income. Only when net income is positive.
P/S2.46xMarket cap / revenue.
P/FCF9.97xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF9.48xMarket cap / cash from operations, when positive.
EV/Sales2.85xEnterprise value / revenue.
EV/EBIT42.5xEnterprise value / operating income, when both are positive.
EV/EBITDA22.2xEnterprise value / EBITDA, when both are positive.
EV/FCF11.5xEnterprise value / free cash flow, when both are positive.
FCF yield10.0%Free cash flow / market cap.
Earnings yield1.7%Net income / market cap (the inverse of P/E).
Shareholder yield6.7%(Dividends paid + share buybacks) / market cap.
What was RingCentral, Inc.'s revenue in fiscal 2025?

RingCentral, Inc. reported revenue of $2.52B for fiscal 2025, 4.8% higher than the year before.

Was RingCentral, Inc. profitable in fiscal 2025?

Yes. Net income was $43.4M, a net margin of 1.7%.

How much free cash flow did RingCentral, Inc. generate in fiscal 2025?

Cash from operations of $617.4M minus capital expenditures of $30.1M left free cash flow of $587.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to RingCentral, Inc.